4VG-33684-07694
2 vaccinations
6 coded responses
8 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 104 / NY
- Registered
- 2021-07-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-07
Dose 1 — Pfizer-BioNTech
-
2021-07-22
Registered in v-safe
- 2021-07-22
-
2021-08-06
Dose 2 — Pfizer-BioNTech
-
2021-08-18
Survey response — day 7, dose 2MedDRA: Fatigue, Lymph node pain — Feeling: Good · Site: Itching · Fatigue or tirednessFree text: I felt achy in my neck glands. A bit tired.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-20
Survey response — day 14, dose 2MedDRA: Fatigue, Gastrointestinal disorder, Headache, Musculoskeletal chest pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pain near/under ribs & some intestinal issues. Almost daily headaches. Very tired.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-27
Survey response — day 21, dose 2MedDRA: Fatigue, Initial insomnia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Mostly just exhaustion and difficulty falling asleep.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-05
Survey response — day 28, dose 2MedDRA: Asthenia, Gastrointestinal disorder, Tachycardia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tachycardia & weakness. Also a change in my digestive system.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-05
Report sent to call center — day 28, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-10
-
2021-09-15
Call successfulParticipant prefers to complete VAERS report online
-
2021-09-17
Survey response — day 42, dose 2MedDRA: Body temperature increased, Diarrhoea, Fatigue, Gastrointestinal disorder, Gastrointestinal pain, Headache, Heart rate increased — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Elevated temperature, headaches, digestive issues (cramps & diarrhea), fast heartbeat, tiredness/general fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Survey response — 6 months, dose 2MedDRA: Asthenia, Dyspnoea, Gastrointestinal disorder, Muscular weakness — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Digestive difficulties & some heart palpitations & breathlessness & some periodic weakness.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-07 | Pfizer-BioNTech | No |
| 2 | 2021-08-06 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — day 7, dose 2
Systemic reaction (other): I felt achy in my neck glands. A bit tired.
Release 9 — day 14, dose 2
Symptoms: Pain near/under ribs & some intestinal issues. Almost daily headaches. Very tired.
Release 9 — day 21, dose 2
Symptoms: Mostly just exhaustion and difficulty falling asleep.
Release 9 — day 28, dose 2
Symptoms: Tachycardia & weakness. Also a change in my digestive system.
Release 9 — day 42, dose 2
Symptoms: Elevated temperature, headaches, digestive issues (cramps & diarrhea), fast heartbeat, tiredness/general fatigue.
Release 11 — 6 months, dose 2
Symptoms: Digestive difficulties & some heart palpitations & breathlessness & some periodic weakness.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | ✓ | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Gastrointestinal disorder | ✓ | · | ✓ |
| SD | Gastrointestinal pain | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Initial insomnia | ✓ | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Musculoskeletal chest pain | ✓ | · | ✓ |
| SD | Tachycardia | ✓ | · | ✓ |
| SRO | Fatigue | ✓ | · | ✓ |
| SRO | Lymph node pain | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release